Bile duct cancer

This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment

This trial is looking at aspirin to try and reduce the risk of cancer for people with primary sclerosing cholangitis and inflammatory bowel disease.

This study is looking at changes to the liver and the immune system which could help diagnose liver cancer at an early stage.

This study is looking at using a blood sample to detect small pieces of DNA released into the blood by cancer cells.

This study is looking at whether the number and types of bacteria that live naturally in our bowel affects how well the treatment for biliary cancer works.

This study is looking at a drug called AZD8205 for solid cancers that have spread to another part of the body or have come back after treatment.

This trial was done to find out if oxaliplatin and 5FU is useful for people with advanced biliary tract cancer who have already had chemotherapy.

This trial was looking at trastuzumab deruxtecan for cancers that had a high number of HER2 receptors (HER2).

This study looked at a blood test called a multi cancer early detection (MCED) test. It is also called the Galleri test.

This study looked at a drug called derazantinib for bile duct cancer.